Axis-Shield Settles Homocysteine Patent Dispute

Law360, New York (July 31, 2008, 12:00 AM EDT) -- Medical diagnostics company Axis-Shield ASA has settled a dispute with Diazyme Laboratories, the life sciences division of California-based General Atomics, over patents for enzymatic homocysteine tests.

The Scotland-based company announced Wednesday that it has agreed to withdraw all patent infringement litigation against Diazyme and its partners. In exchange, Diazyme will withdraw opposition to Axis-Shield's homocysteine patents outside the U.S. and license them from Axis-Shield.

The companies’ enzymatic homocysteine assays test whether a person has a high level of the amino acid homocysteine, which could indicate the...
To view the full article, register now.